Last reviewed: June 5, 2026

Last updated: June 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight loss on semaglutide varies widely between individuals, ranging from 5% to 22% of starting body weight depending on dose, adherence, and metabolic factors. PlexusDx offers personalized semaglutide therapy through licensed 503A compounding pharmacies across all 50 states, helping patients achieve their weight reduction goals affordably.

Typical Semaglutide Weight Loss Outcomes in Clinical Trials

The landmark STEP 1 trial demonstrated that adults using semaglutide lost an average of 14.9% of their body weight compared to 2.4% in the placebo group over 68 weeks. Participants on the highest maintenance dose achieved reductions closer to 17.4%, with some individuals losing as much as 22% of their initial weight. These results represent significant metabolic improvement and typically translate to meaningful changes in health markers like blood pressure, cholesterol, and blood glucose.

Real-world outcomes from clinical practice often mirror trial results, though individual responses depend on starting weight, age, activity level, and medication adherence. Patients beginning semaglutide therapy should anticipate gradual weight loss over months rather than weeks, with the most substantial reductions appearing between weeks 12 and 52 of consistent use. Starting weight plays a role in absolute pounds lost—a person weighing 250 pounds may lose 50 to 55 pounds at higher doses, while someone at 180 pounds might lose 27 to 40 pounds.

How Individual Genetics Influence Your Weight Loss Response

Your genetic makeup affects how effectively semaglutide works for weight management. The GLP1R rs6923761 variant, the GIPR rs1800437 polymorphism, and the FTO rs9939609 single nucleotide polymorphism all influence how your body responds to GLP-1 pathway activation. PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways and 49 peptides to reveal which genetic factors may enhance or limit your weight loss potential on semaglutide therapy.

Understanding your peptide-pathway genetics helps PlexusDx clinicians optimize your starting dose and adjust your protocol for maximum results. Patients with favorable genetic profiles at key receptor sites often experience faster initial weight loss and greater total body weight reduction. The $99 genetic test (available as an add-on after your first month of semaglutide treatment) provides actionable insights into your metabolic predispositions, allowing for truly personalized dosing strategies.

Factors That Affect Your Personal Weight Loss Timeline

Weight loss on semaglutide follows a dose-escalation schedule that typically spans 16 to 20 weeks, during which your body adapts to the medication while your appetite suppression strengthens. Patients who maintain consistent injection schedules, follow nutritional guidance, and engage in regular physical activity tend to achieve weight loss targets faster and sustain them longer. Metabolic factors like thyroid function, baseline insulin resistance, and sleep quality also influence how quickly pounds come off.

PlexusDx compounded semaglutide injections are available at a flat rate starting at $149 per month—your dose may need to go up, but your price won't. This pricing transparency removes barriers to dose optimization, allowing patients to reach therapeutic doses without cost escalation worries. Adherence improves when patients understand that higher doses are not tied to higher monthly bills, supporting better long-term weight management outcomes.

Comparing Semaglutide to Other GLP-1 Weight Loss Options

Semaglutide injections (brand-name Ozempic or Wegovy equivalents) produce weight loss comparable to tirzepatide but act through a single GLP-1 receptor mechanism. PlexusDx offers both compounded semaglutide injections starting at $149/month and oral semaglutide at $249/month, as well as dual-compound GLP-Squared products that combine semaglutide with tirzepatide for patients seeking enhanced metabolic targeting. Clinical evidence shows tirzepatide (which activates both GLP-1 and GIP receptors) may produce slightly greater weight reduction in some populations, though individual responses vary considerably.

Oral semaglutide provides convenience for needle-averse patients but requires specific administration protocols to ensure absorption. PlexusDx also offers the Microdose GLP-1 Protocol at $129/month for patients beginning their weight loss journey or preferring a gentler metabolic approach. All medications come from licensed 503A compounding pharmacies, require no insurance or membership fees, and are HSA/FSA eligible, making precision weight loss accessible regardless of insurance status.

Sustaining Weight Loss After Reaching Your Goal

Weight regain occurs in 30% to 50% of patients who discontinue semaglutide, emphasizing that ongoing treatment maintains the metabolic benefits that produced initial weight loss. The appetite-suppressing effects of semaglutide decline within weeks of stopping injections, making long-term adherence essential for weight maintenance. PlexusDx patients benefit from flexible dosing plans designed to support both weight loss phases and long-term weight maintenance at lower, sustainable doses.

Lifestyle modifications including strength training, protein intake optimization, and sleep hygiene amplify semaglutide's effects and help lock in weight loss gains over years rather than months. Many PlexusDx patients stabilize on maintenance doses lower than peak weight loss doses, reducing overall treatment costs while preserving metabolic advantages. Regular follow-up consultations help fine-tune your protocol as your body's needs evolve.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight should I realistically expect to lose in the first month on semaglutide?

Most patients lose 2 to 5 pounds in the first four weeks as the starting dose is typically low and your body is adjusting to appetite suppression. Significant weight loss accelerates during weeks 5 through 16 as your dose increases during the titration phase.

Do men and women lose weight differently on semaglutide?

Clinical trials show similar percentage weight loss between genders, though absolute pounds lost may differ based on starting weight and muscle mass.

Can I use semaglutide if I have a history of weight regain after previous diets?

Yes—semaglutide is especially valuable for individuals with chronic weight regain patterns because it addresses the biological appetite-drive mechanisms that cause relapse.

What happens to weight loss if I miss doses of semaglutide?

Missing doses slows weight loss momentum and may trigger increased appetite within days, potentially reversing progress. Maintaining a consistent weekly injection schedule is critical for sustained results.

How does the Precision Peptide Genetic Test predict my personal weight loss potential?

The test identifies your genetic variants in GLP1R, GIPR, FTO, MC4R, and 10 other metabolic pathway genes, revealing whether your genetics favor rapid response to semaglutide or suggest a need for alternative strategies.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves